ReviewCurrent diabetes reports2016

Safety and Tolerability of Glucagon-Like Peptide-1 Receptor Agonists Utilizing Data from the Exenatide Clinical Trial Development Program.

Hui Peng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.